Electromed (ELMD) Stock Overview
Develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for ELMD from our risk checks.
ELMD Community Fair Values
Create NarrativeSee what 11 others think this stock is worth. Follow their fair value or set your own to get alerts.
Electromed, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$24.63 |
| 52 Week High | US$35.56 |
| 52 Week Low | US$17.73 |
| Beta | 0.27 |
| 1 Month Change | 1.40% |
| 3 Month Change | 28.55% |
| 1 Year Change | -12.29% |
| 3 Year Change | 137.74% |
| 5 Year Change | 157.10% |
| Change since IPO | 518.84% |
Recent News & Updates
Recent updates
The Triple Down On Bronchiectasis Campaign Will Expand SmartVest Clearway's Market Reach
Diversifying beyond homecare and investing in sales efforts may drive revenue growth and improve earnings through expanded market channels and effective sales execution.What Percentage Of Electromed, Inc. (NYSEMKT:ELMD) Shares Do Insiders Own?
Mar 07
Is Electromed, Inc.'s (NYSEMKT:ELMD) Latest Stock Performance A Reflection Of Its Financial Health?
Feb 17
Shareholder Returns
| ELMD | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.4% | 0.09% | -2.7% |
| 1Y | -12.3% | 0.4% | 11.9% |
Return vs Industry: ELMD underperformed the US Medical Equipment industry which returned 2.3% over the past year.
Return vs Market: ELMD underperformed the US Market which returned 14.1% over the past year.
Price Volatility
| ELMD volatility | |
|---|---|
| ELMD Average Weekly Movement | 8.6% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.1% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: ELMD has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ELMD's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 179 | Jim Cunniff | smartvest.com |
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting.
Electromed, Inc. Fundamentals Summary
| ELMD fundamental statistics | |
|---|---|
| Market cap | US$210.77m |
| Earnings (TTM) | US$8.20m |
| Revenue (TTM) | US$66.22m |
Is ELMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ELMD income statement (TTM) | |
|---|---|
| Revenue | US$66.22m |
| Cost of Revenue | US$14.54m |
| Gross Profit | US$51.68m |
| Other Expenses | US$43.48m |
| Earnings | US$8.20m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.98 |
| Gross Margin | 78.04% |
| Net Profit Margin | 12.38% |
| Debt/Equity Ratio | 0% |
How did ELMD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/17 22:34 |
| End of Day Share Price | 2025/11/17 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Electromed, Inc. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kyle Bauser | B. Riley Securities, Inc. |
| Anderson Schock | B. Riley Securities, Inc. |
| Ilya Zubkov | Freedom Broker |